A detailed history of Bank Ozk transactions in Amgen Inc stock. As of the latest transaction made, Bank Ozk holds 11,964 shares of AMGN stock, worth $3.84 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
11,964
Previous 11,786 1.51%
Holding current value
$3.84 Million
Previous $3.35 Million 11.58%
% of portfolio
1.64%
Previous 1.52%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $46,769 - $56,837
178 Added 1.51%
11,964 $3.74 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $56,462 - $68,157
210 Added 1.81%
11,786 $3.35 Million
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $37,076 - $41,826
145 Added 1.27%
11,576 $3.33 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $158,521 - $196,808
-725 Reduced 5.96%
11,431 $3.07 Million
Q2 2023

Jul 27, 2023

SELL
$214.27 - $253.37 $412,041 - $487,230
-1,923 Reduced 13.66%
12,156 $2.7 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $65,704 - $80,083
-291 Reduced 2.03%
14,079 $3.4 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $26,567 - $33,757
-116 Reduced 0.8%
14,370 $3.77 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $22,221 - $25,061
-99 Reduced 0.68%
14,486 $3.27 Million
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $54,908 - $61,104
-238 Reduced 1.61%
14,585 $3.55 Million
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $38,372 - $42,449
175 Added 1.19%
14,823 $3.59 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $56,879 - $65,093
-286 Reduced 1.92%
14,648 $3.3 Million
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $66,865 - $78,340
-315 Reduced 2.07%
14,934 $3.18 Million
Q2 2021

Aug 02, 2021

BUY
$233.58 - $259.14 $14,481 - $16,066
62 Added 0.41%
15,249 $3.72 Million
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $51,261 - $59,736
-231 Reduced 1.5%
15,187 $3.78 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $16,444 - $19,582
-76 Reduced 0.49%
15,418 $3.55 Million
Q3 2020

Oct 21, 2020

SELL
$234.65 - $260.95 $94,798 - $105,423
-404 Reduced 2.54%
15,494 $3.94 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $22,748 - $27,915
115 Added 0.73%
15,898 $3.75 Million
Q1 2020

May 04, 2020

SELL
$182.24 - $241.7 $63,784 - $84,595
-350 Reduced 2.17%
15,783 $3.2 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $39,544 - $50,828
209 Added 1.31%
16,133 $3.89 Million
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $85,313 - $102,223
-490 Reduced 2.99%
15,924 $3.08 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $35,673 - $41,817
-214 Reduced 1.29%
16,414 $3.03 Million
Q1 2019

Apr 25, 2019

BUY
$180.87 - $203.88 $10,852 - $12,232
60 Added 0.36%
16,628 $3.16 Million
Q4 2018

Jan 24, 2019

BUY
$178.4 - $208.25 $7,136 - $8,330
40 Added 0.24%
16,568 $3.23 Million
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $77,080 - $86,898
-416 Reduced 2.46%
16,528 $3.43 Million
Q2 2018

Aug 02, 2018

BUY
$166.05 - $186.51 $8,800 - $9,885
53 Added 0.31%
16,944 $3.13 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $233,305 - $272,646
-1,377 Reduced 7.54%
16,891 $2.88 Million
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $76,968 - $85,997
-456 Reduced 2.44%
18,268 $3.18 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $3.13 Million - $3.58 Million
18,724
18,724 $3.49 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Ozk Portfolio

Follow Bank Ozk and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Ozk, based on Form 13F filings with the SEC.

News

Stay updated on Bank Ozk with notifications on news.